A war to win by Guallar Garrido, Sandra & Universitat Autònoma de Barcelona. Facultat de Biociències
The six main species of microorganisms that easily develop resistances to antibiotics 
are called ESKAPE because of their initials. As well, referring their ability 
to evade treatments. 
Has Vall Hebron mechanisms to 
control  dissemination of 
multiresistant pathogens? 
First of all, we  just prescribe new 
antibiotics in cases of 
multiresistance. Afterwards, we 
analyse  samples of risk people to 
determinate if they have or not 
multiresistent bacteria. 
If you could give an advice, it 
will be...
As soon as we discover an 
effective antibiotic, a resistance 
appears. For this reason, we need 
to do a good use of antibiotics. 
Not just people in theirs homes, 
doctors too. 
A bit of Juanjo González
Antibiotic resistance is the microorganism’s capacity of
surviving during a treatment with antibiotics.
Microorganisms can be resistant to one or more antibiotics.
. 
Do not treat yourself, just if the doctor says. 
Ask for microbiological tests to make sure it is the right  treatment.
Wash your hands to stop infections. 
Get vaccinated.  It protects against infections.
Do not ask for antibiotics when your doctor thinks they are unnecessary.
Do not re-use. They might loose their efficacy or you may need another treatment.
Take antibiotics prescribed only for you. Treatments are specific for each microorganism.
klebsiella
pneumoniae
Antibiotics have been used in a lot of situations. Unfortunately, there are more and more 
infections without effective treatment due to a bad use.  For this reason, we need to use 
correctly the treatments that we have. 
Initially K. neumoniae was an important 
community's pathogen. Few years later, it 
was established in the hospital environment 
causing pneumonia and urinary infections.
About 75-88% of clinical infections are 
associated with K. pneumoniae. 
Furthermore, it can do biofilms (a layer that 
protects from environment)  on medical 
devices like catheters, which complicates the 
treatment. 
Although  most of the infected patients are 
young, the mortality ranges from 3 to 42%.
Moreover, survivors usually 
have squeals. 
E. faecium belongs to the enterococci
group. Normally, enterococci are 
present in  gastrointestinal microbiota. 
However, infection occurs when the number 
of this group increases.
They can survive on a lot of surfaces and they 
are resistant to cleaning products. 
These characteristics promote a wide 
distribution in hospital environments. 
In 1980, E. faecium was sensitive to 
vancomycin, but in 2007 more 
than 80% of E. faecium
became resistant.
Enterobacteriaceae are a group of 
microorganisms.
•Salmonella: Infection due to uncooked food 
or contaminated water. The major symptoms 
are gastroenteritis and fever.
•Escherichia coli: It produces an autoinfection. 
It causes meningitis in neonates, blood and 
urinary infections. 
•Shigella:  It is rarely founded in microbiota. It 
can be transmitted by food or contaminated 
water. It causes 165 milions of 
infections every year and 
more than 1 million
deaths.
Enterobacteriaceaeenterococcus
faecium
S. aureus can be found in 
different parts of the body. Carriage is 
asymptomatic  and it varies with sex, 
age or geographic location .
However, It is an opportunistic pathogen that  
can cause from infection to death.
Penicillin was the first treatment used, but in the 
1950s more than 50% of S. aureus were resistant 
to it. Methicillin was the next antibiotic used. 
Two years later, Methicillin Resistant 
Staphylococcus aureus (MRSA)  were found.
Nowadays, MRSA is over the world. In fact, it is 
the main infection associated to 
European hospitals.
Staphylococcus
aureus
How do you prevent antibiotic resistance?
What should doctors do?
By the 1980s, P. aeruginosa became
an important  causal agent of pneumonia in 
hospitals and burn wound infections. Now, it 
is responsible from 10 to 15% of ICUs 
infections and between people with chronic 
lung diseases.
P. aeruginosa is resistant to different 
antibiotics, so colistin or combination 
therapy are some treatment  options. 
Hospitalization for patients with 
susceptible P. aeruginosa  infections 
costs 22.116$. However, the cost 
increases to 54.081$ in the cases of 
resistance. 
Pseudomonas
aeruginosa
A WAR TO WIN
•Prescribe correctly: dose, duration and indications.
•Knowledge of resistances in their areas.
•Good use. New antibiotics only for multiresistance
cases. 
•Identify the pathogen for a good treatment. 
•Hygiene controls with every patient.
acinetobacter
baumannii
A. baumannii rarely is forming part of 
human’s microbiota. It can affect skin and  
respiratory tract especially  in a military 
environment or in accidents or wounds. 
This microorganism generates a medical 
alarm inside Intensive Care Units  (ICUs) as 
well as in immunocompromised individuals. 
The principal pathologies are  pneumonia 
and meningitis. 
In 1970 it have sensitivity to most 
antibiotics,  but nowadays  it shows a lot of 
resistances. The diversity of treatments 
shows  the lack of effective therapy.
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